Information on medicinal products traded illegally in Romania on the German market
2014.09.15
Active substance: rituximab, trastuzumab
The Romanian medicines licensing authority (ANMDM) has informed the Federal Institute for Drugs and Medical Devices (BfArM) and the Paul-Ehrlich-Institut (PEI) via the European Rapid Alert System that batches of 45 medicinal products traded by the Romanian wholesale distributor Chemomed are being recalled.
risk information - full text (available in German only)